Screening EGFR Mutations in NSCLC by Immunohistochemistry

被引：0
作者：
Gaber, Rania [1 ]
Watermann, Iris [2 ]
Vollmer, Ekkehard [2 ]
Goldmann, Torsten [2 ]
机构：
[1] Univ Alexandria, Fac Med, Pathol, Alexandria, Egypt
[2] Res Ctr Borstel, Clin & Expt Pathol, Borstel, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
EGFR mutations; DNA sequencing; NSCLC; Immunohistochemistry;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-015
引用
收藏
页码：S582 / S583
页数：2
相关论文
共 50 条
  • [31] Afatinib for the Treatment of NSCLC Harboring Uncommon EGFR Mutations: A Database of 693 Cases
    Yang, James Chih-Hsin
    Schuler, Martin
    Popat, Sanjay
    Miura, Satoru
    Heeke, Simon
    Park, Keunchil
    Maerten, Angela
    Kim, Edward S.
    JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (05) : 803 - 815
  • [32] Treatment for Advanced NSCLC with EGFR Mutations and De Novo MET Amplification/Overexpression
    Wang, H.
    Li, W.
    Deng, Q.
    Kang, J.
    Chen, H.
    Wang, Z.
    Zhou, Q.
    Xu, C.
    Zhang, X.
    Su, J.
    Yan, H.
    Wu, Y.
    Yang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S393 - S393
  • [33] Systemic Therapy for Oligoprogression in Patients with Metastatic NSCLC Harboring Activating EGFR Mutations
    Rossi, Antonio
    Galetta, Domenico
    CANCERS, 2022, 14 (03)
  • [34] Comparison of circulating DNA from plasma and urine for EGFR mutations in NSCLC patients
    Zhang, Hao
    He, Bin
    Cui, Jun
    Zhao, Mingzhang
    Zhang, Zengwang
    CANCER BIOMARKERS, 2018, 23 (03) : 427 - 436
  • [35] Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
    Hackner, Klaus
    Buder, Anna
    Hochmair, Maximilian J.
    Strieder, Matthaeus
    Grech, Christina
    Fabikan, Hannah
    Burghuber, Otto C.
    Errhalt, Peter
    Filipits, Martin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [36] A Randomized Study of Concurrent vs Sequential Alternating EGFR-TKIs and Chemotherapy for Advanced NSCLC with EGFR Mutations
    Yong, H.
    Hui, L.
    Fang, L.
    Dong, L.
    Ling, X.
    Qiang, W.
    Peng, X.
    Hua, H.
    Yang, Y.
    Ping, G.
    Cui, K.
    Wu, W.
    Yu, C.
    Huo, L.
    Qiang, X.
    Xi, S.
    Jin, C.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S592 - S593
  • [37] EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report
    Kamila, Wojas-Krawczyk
    Michal, Skronski
    Pawel, Krawczyk
    Paulina, Jagus
    Tomasz, Kucharczyk
    Bozena, Jarosz
    Radoslaw, Mlak
    Justyna, Szumilo
    Marek, Sawicki
    Trojanowski, Tomasz
    Janusz, Milanowski
    Joanna, Chorostowska-Wynimko
    CLINICAL & EXPERIMENTAL METASTASIS, 2013, 30 (08) : 1063 - 1071
  • [38] Gene Mutations in Squamous Cell NSCLC: Insignificance of EGFR, KRAS and PIK3CA Mutations in Prediction of EGFR-TKI Treatment Efficacy
    Fiala, Ondrej
    Pesek, Milos
    Finek, Jindrich
    Benesova, Lucie
    Bortlicek, Zbynek
    Minarik, Marek
    ANTICANCER RESEARCH, 2013, 33 (04) : 1705 - 1711
  • [39] Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study
    Soo, Ross A.
    Reungwetwattana, Thanyanan
    Perroud, Herman Andres
    Batra, Ullas
    Kilickap, Saadettin
    Gallegos, Luis Fernando Tejado
    Donner, Natalia
    Alsayed, Mohamed
    Huggenberger, Reto
    Tu, Dao Van
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : 1449 - 1459
  • [40] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
12345